“For insurers imposing restrictions, capping caps on prescription opioids is a fairly easy thing that they could do. The more difficult thing for them to do is increase the funding ... for drug treatment services,” says drug fellow Katharine Neill. KPRC-TV: https://bit.ly/2Gqafeu